Skip to main content
ArticleOPEN ACCESS

Bilateral anterior uveitis after BNT162b2 mRNA vaccine: Case report

Journal Francais d'Ophtalmologie
DOI: 10.1016/j.jfo.2022.04.004
2Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

References Powered by Scopus

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

New England Journal of Medicine
10934Citations
N/AReaders
Get full text

Uveitis after the bnt162b2 mrna vaccination against sars-cov-2 infection

Retina
101Citations
N/AReaders
Get full text

Uveitis and other ocular complications following covid-19 vaccination

Journal of Clinical Medicine
99Citations
N/AReaders
Get full text
View more at Scopus

Cited by Powered by Scopus

COVID-19 Vaccine-Associated Ocular Adverse Effects: An Overview

Vaccines
19Citations
N/AReaders
Get full text

The Characteristics of COVID-19 Vaccine-Associated Uveitis: A Summative Systematic Review

Vaccines
14Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Duran, M. (2022, September 1). Bilateral anterior uveitis after BNT162b2 mRNA vaccine: Case report. Journal Francais d’Ophtalmologie. Elsevier Masson s.r.l. https://doi.org/10.1016/j.jfo.2022.04.004

Readers' Seniority

Tooltip

Researcher 1

100%

Readers' Discipline

Tooltip

Social Sciences 1

100%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 3

Save time finding and organizing research with Mendeley

Sign up for free